Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes
© 2015 by the Endocrine Society. Although the cardioprotective effects of glucagon-like peptide-1 and its analogs have been reported, the exact mechanisms of the glucagon-like peptide-1 receptor (GLP-1R) signaling pathway in the heart are still unclear. Activation of the GLP-1R has been shown to inc...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
The Endocrine Society
2015
|
Subjects: | |
Online Access: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84926335902&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38447 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-38447 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-384472015-06-16T07:47:14Z Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes Mangmool S. Hemplueksa P. Parichatikanond W. Chattipakorn N. Chattipakorn N. Molecular Biology Endocrinology © 2015 by the Endocrine Society. Although the cardioprotective effects of glucagon-like peptide-1 and its analogs have been reported, the exact mechanisms of the glucagon-like peptide-1 receptor (GLP-1R) signaling pathway in the heart are still unclear. Activation of the GLP-1R has been shown to increase cAMP levels, thus eliciting protein kinase A- and exchange protein activated by cAMP (Epac)-dependent signaling pathways in pancreatic b-cells. However, which pathway plays an important role in the antioxidant and antiapoptotic effects of GLP-1R activation in the heart is not known. In this study, we demonstrated that stimulation of GLP-1Rs with exendin-4 attenuated H<inf>2</inf>O<inf>2</inf>-induced reactive oxygen species production and increased the synthesis of antioxidant enzymes, catalase, glutathione peroxidase-1, and manganese superoxide dismutase that is dependent on Epac. Additionally, exendin-4 has an antiapoptotic effect by decreasing a number of apoptotic cells, inhibiting caspase-3 activity, and enhancing the expression of antiapoptotic protein B-cell lymphoma 2, which is mediated through both protein kinase A- and Epac-dependent pathways. These data indicate a critical role for Epac in GLP-1R-mediated cardioprotection. 2015-06-16T07:47:14Z 2015-06-16T07:47:14Z 2015-01-01 Article 08888809 2-s2.0-84926335902 10.1210/me.2014-1346 http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84926335902&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38447 The Endocrine Society |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
topic |
Molecular Biology Endocrinology |
spellingShingle |
Molecular Biology Endocrinology Mangmool S. Hemplueksa P. Parichatikanond W. Chattipakorn N. Chattipakorn N. Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes |
description |
© 2015 by the Endocrine Society. Although the cardioprotective effects of glucagon-like peptide-1 and its analogs have been reported, the exact mechanisms of the glucagon-like peptide-1 receptor (GLP-1R) signaling pathway in the heart are still unclear. Activation of the GLP-1R has been shown to increase cAMP levels, thus eliciting protein kinase A- and exchange protein activated by cAMP (Epac)-dependent signaling pathways in pancreatic b-cells. However, which pathway plays an important role in the antioxidant and antiapoptotic effects of GLP-1R activation in the heart is not known. In this study, we demonstrated that stimulation of GLP-1Rs with exendin-4 attenuated H<inf>2</inf>O<inf>2</inf>-induced reactive oxygen species production and increased the synthesis of antioxidant enzymes, catalase, glutathione peroxidase-1, and manganese superoxide dismutase that is dependent on Epac. Additionally, exendin-4 has an antiapoptotic effect by decreasing a number of apoptotic cells, inhibiting caspase-3 activity, and enhancing the expression of antiapoptotic protein B-cell lymphoma 2, which is mediated through both protein kinase A- and Epac-dependent pathways. These data indicate a critical role for Epac in GLP-1R-mediated cardioprotection. |
format |
Article |
author |
Mangmool S. Hemplueksa P. Parichatikanond W. Chattipakorn N. Chattipakorn N. |
author_facet |
Mangmool S. Hemplueksa P. Parichatikanond W. Chattipakorn N. Chattipakorn N. |
author_sort |
Mangmool S. |
title |
Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes |
title_short |
Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes |
title_full |
Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes |
title_fullStr |
Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes |
title_full_unstemmed |
Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes |
title_sort |
epac is required for glp-1r-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes |
publisher |
The Endocrine Society |
publishDate |
2015 |
url |
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84926335902&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38447 |
_version_ |
1681421475262758912 |